share_log
Breakings ·  Nov 18, 2024 19:25
Ascendis Pharma A/S : Citigroup Cuts Target Price to $200 From $207
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment